The purpose of the study is to assess whether magnesium sulphate for women at risk of preterm
birth can protect their children against cerebral palsy. The results from this randomised
controlled trial will be added to the previous meta-analysis to obtain firm evidence for
magnesium sulphate as a neuroprotector, and determine whether it should be used as standard
therapy for women in preterm birth.